MIR8083

Across TCGA pan-cancer cohorts, MIR8083 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated MIR8083 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MIR8083 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR8083 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LUAD show a favorable association.

BLCA, BRCA, and ESCA are the cancer types where MIR8083 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	All	0.248	0.608	.003	60	view →
BRCA	DFS	Tertile	All	0.140	1.000	.001	48	view →
ESCA	DFS	Tertile	All	0.623	0.313	.004	39	view →
CESC	OS	Tertile	IV	0.121	0.591	.029	36	view →
UCEC	DFS	Tertile	All	0.778	0.856	.012	36	view →
LUAD	OS	Tertile	All	0.896	0.791	.007	33	view →
MESO	DFS	Quartile	II,III,IV	0.492	0.237	.006	32	view →
READ	OS	Tertile	All	0.222	0.845	<.001	30	view →
LGG	OS	Tertile	All	0.643	0.823	.003	27	view →
KIRC	DFS	Tertile	II,III,IV	0.528	0.713	.013	18	view →
SKCM	DFS	Tertile	IV	0.043	0.518	.001	18	view →
TGCT	OS	Tertile	All	0.897	0.985	.046	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

MIR8083–BLCA (DFS)

Open the BLCA breakdown →